Fungal Infection Diagnosis Market by 2028 | Global Forecast, Trends, Opportunity and Industry Analysis

Latest research report on “Fungal Infection Diagnosis Market” now available at high quality database of with market size, share, trends, competitive and statistical analysis. An exclusive data offered in this report is collected by research and industry experts team.

Get Free Sample Copy @

Invasive candidiasis is an infection caused by a yeast (a type of fungus) called Candida. Unlike Candida infections in the mouth and throat (also called “thrush”) or vaginal “yeast infections,” invasive candidiasis is a serious infection that can affect the blood, heart, brain, eyes, bones, and other parts of the body. Candidemia, a bloodstream infection with Candida, is a common infection in hospitalized patients
At present, most hospitals are carrying out non-invasive laboratory diagnosis techniques such as G test and GM test.
This report contains market size and forecasts of Fungal Infection Diagnosis in Global, including the following market information:
Global Fungal Infection Diagnosis Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Fungal Infection Diagnosis market was valued at 19 million in 2021 and is projected to reach US$ 30 million by 2028, at a CAGR of 7.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Galactomannan Test Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Fungal Infection Diagnosis include ASSOCIATES OF CAPE COD, BioRad, IMMY, Beijing Jinshanchuan, Danna Biological and Zhanjiang A & C Biological Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Fungal Infection Diagnosis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:
Global Fungal Infection Diagnosis Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Fungal Infection Diagnosis Market Segment Percentages, by Type, 2021 (%)
– Galactomannan Test
– (1 to 3)-?-D-glucan Experiment
Global Fungal Infection Diagnosis Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Fungal Infection Diagnosis Market Segment Percentages, by Application, 2021 (%)
– Hospital
– Laboratory
– Others
Global Fungal Infection Diagnosis Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Fungal Infection Diagnosis Market Segment Percentages, By Region and Country, 2021 (%)
– North America
– – US
– – Canada
– – Mexico
– Europe
– – Germany
– – France
– – U.K.
– – Italy
– – Russia
– – Nordic Countries
– – Benelux
– – Rest of Europe
– Asia
– – China
– – Japan
– – South Korea
– – Southeast Asia
– – India
– – Rest of Asia
– South America
– – Brazil
– – Argentina
– – Rest of South America
– Middle East & Africa
– – Turkey
– – Israel
– – Saudi Arabia
– – UAE
– – Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Fungal Infection Diagnosis revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Fungal Infection Diagnosis revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
– BioRad
– Beijing Jinshanchuan
– Danna Biological
– Zhanjiang A & C Biological Ltd.

More information about Discount offers (20% or More)  @

About Us: is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
We provide 24/7 online and offline support to our customers.

E-mail: [email protected]

Phone: +1 888 391 5441

Share This Post

Post Comment